Lambipol

Lamotrigine, the active ingredient in Lambipol, is an anticonvulsant presented as an oral tablet for oral use. It is used to control seizures in epilepsy and to stabilize mood in bipolar disorder, primarily in adult patients.

GNH USA supplies Lambipol as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable global distribution. Products are manufactured under EU GMP guidelines and exported to multiple regulatory markets, ensuring consistent potency and safety for patients worldwide.

Lamotrigine is used in the management of seizure disorders and mood stabilization, targeting neuronal excitability. - Epilepsy: Reduces frequency and severity of partial and generalized seizures. - Bipolar disorder: Helps prevent recurrence of manic and depressive episodes.

Lamotrigine may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Dizziness: Light‑headed feeling or loss of balance. - Headache: Mild to moderate pain in the head. - Nausea: Feeling of stomach upset or urge to vomit. - Rash: Skin redness or mild itching. - Fatigue: Generalized tiredness or lack of energy. - Blurred vision: Temporary visual disturbances. - Insomnia: Difficulty falling or staying asleep. - Tremor: Involuntary shaking of hands or limbs.

Serious or Rare Side Effects: - Stevens‑Johnson syndrome: Severe skin reaction with blistering and mucosal involvement. - Toxic epidermal necrolysis: Life‑threatening skin detachment. - Aseptic meningitis: Inflammation of the meninges without infection. - Hematologic abnormalities: Low white blood cell or platelet counts. - Severe hypersensitivity: Swelling of face, lips, or throat. - Liver injury: Elevated enzymes or hepatitis.

When prescribing Lamotrigine, clinicians should consider several safety measures. - Initiate therapy gradually: Start with low dose and increase slowly to reduce rash risk. - Monitor skin reactions: Discontinue immediately if a rash develops. - Assess hepatic function: Use caution in patients with liver impairment. - Review concomitant medications: Adjust dose when combined with enzyme‑inducing drugs. - Avoid use in patients with known hypersensitivity to lamotrigine. - Store at ambient temperature below 25°C: Keep in original packaging, protect from moisture and light.

Lamotrigine interacts with several drugs that can alter its plasma levels or increase adverse effects.

Major Interactions (Avoid): - Valproic acid: Increases lamotrigine levels, risk of toxicity; dose reduction required. - Carbamazepine: Decreases lamotrigine levels, may reduce efficacy; dose increase may be needed.

Moderate Interactions (Monitor Closely): - Oral contraceptives: Decrease lamotrigine clearance, may raise concentrations; monitor for side effects. - Phenobarbital: Lowers lamotrigine levels, may require dose adjustment. - Phenytoin: Reduces lamotrigine concentrations, monitor seizure control. - Rifampicin: Increases metabolism of lamotrigine, may diminish effect.